04/03/2025
Colore**al cancer remains the third most common cancer and the second leading cause of cancer-related deaths worldwide. While a healthy lifestyle can help lower individual risk, early detection through screening is life-saving. Those experiencing persistent symptoms or reaching screening age should seek medical advice—because early intervention saves lives.
At SurgEase Innovations Ltd, we are deeply committed to reducing the burden of colore**al cancer. Our journey with LumenEye® has always been about making a meaningful difference—from early detection to treatment planning and follow-up. With over 350 systems in use globally, LumenEye is empowering surgeons, gastroenterologists, GPs, nurses, and oncologists to enhance patient care.
Every day, hundreds of patients are screened using LumenEye. We take pride in knowing that our work is playing a role in transforming outcomes and helping clinicians detect disease sooner. As we mark Colore**al Cancer Awareness Month, let’s continue the conversation on how technology and innovation can drive better care for all.
**alCancerAwareness
